Because inflammatory and immunological consequences cannot be studied properly in skin fibroblasts and PBMCs are difficult to obtain, we introduced MK deficiency in the human THP-1 monocyte cell line using the CRISPR/Cas9 genome editing technology. This evidence concerns the gene MVK and hyperinsulinemic hypoglycemia, familial, 4.